Skip to main content
Equibles

Robertson H. Gilliland

Board Member

Azora Therapeutics, Inc. (DE) (AZR)

Equibles does not estimate personal net worth.

Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.

Get AZR alerts

About Robertson H. Gilliland

Robertson H. Gilliland is recorded as Board Member at Azora Therapeutics, Inc. (DE) (AZR) since September 17, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed September 18, 2026 that Robertson H. Gilliland was appointed Class II director, effective September 17, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.

“The Company's stockholders elected each of Cary J. Claiborne and Robertson H. Gilliland as a Class II director, to serve until the 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualified, with the following votes:”
Azora Therapeutics, Inc. (DE) Form 8-K, filed September 18, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Azora Therapeutics, Inc. (DE)

Recent activity